Skip to search formSkip to main contentSkip to account menu

teplizumab

Known as: Immunoglobulin G1, Anti-(Human CD3 (Antigen)Epsilon-Chain)(Human-Mouse Monoclonal MGA031 Heavy Chain), Disulfide with Human-Mouse Monoclonal MGA031 Light-Chain Dimer, hOKT3gamma1(Ala-Ala), humanized OKT3 gamma1(Ala-Ala) 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Antibodies, Monoclonal, Humanized
antigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Preventing Type 1 Diabetes with Teplizumab
Because type 1 diabetes mellitus (DM) is the result of immune destruction of pancreatic islet cells, immunologic interventions… 
2019
2019
Treatment Delays Onset of Diabetes in At-Risk Populations
A single course of treatment with teplizumab delayed the development of type 1 diabetes in at-risk teens and children, shows a… 
2019
2019
DTC pharmacogenomics testing under scrutiny
77 new-onset patients, a team led by Benaroya immunologists Alice Long and Peter Linsley probed gene expression profiles in the… 
2017
2017
J Endocrinol 2017, 1(2): 000107
The incidence of type 1 diabetes mellitus (T1DM) is increasing at a massive pace globally. It results possibly from a genetic… 
2015
2015
Fcr Non-Binding Anti-Cd3 Mab (teplizumab) Inactivates Cd8+ Central Memory Cells In Patients With Type 1 Diabetes And Identifies Responders To Treatment
2013
2013
Improving animal research
(NIAID) trial now suggest the tide could be turning. Protégé investigator Kevan Herold, of Yale University, and his colleagues… 
Review
2013
Review
2013
DIABETIC STUDIES The Review of Chapter IV . 2 CD 3 Monoclonal Antibodies : A First Step Towards Operational Immune Tolerance in the Clinic
Type 1 diabetes (T1D) is a prototypic organ-specific autoimmune disease resulting from the selective destruction of insulin… 
2012
2012
Ablynx drops lead nanobody
Prospects for Israeli company Andromeda Biotech were bolstered late last year with the news that its synthetic peptide, DiaPep277… 
2012
2012
India's innovation czar
Prospects for Israeli company Andromeda Biotech were bolstered late last year with the news that its synthetic peptide, DiaPep277… 
2011
2011
More than insulin
For a century, insulin has been the only drug available to type 1 diabetics. Now a raft of novel drugs are coming through the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)